InvestorWire NewsRoom


Articles Category: CBD
Wednesday Apr 27, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Launches Fourth Human Study for Reducing Hypertension, Reports Positive Outcome of Third Human Study’s Data

Global drug delivery innovator Lexaria Bioscience is researching the ability of its patented DehydraTECH(TM) technology to improve the performance of a number of prescription drugs Lexaria is a world leader in the investigation of a DehydraTECH-processed cannabidiol (“CBD”) to potentially treat high blood pressure (hypertension), and study outcomes thus far have rendered positive results on effectiveness and patient toleranceThe company is building a scorecard of data…

Continue Reading

Monday Apr 25, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Advancing DehydraTECH-Nicotine Research to Support Safer, More Effective Oral Alternative to Harmful Pulmonary Administration Practices

Lexaria expects to begin dosing this summer as part of a human nicotine study, NIC-H22-1, to compare DehydraTECH-nicotine pouch performance to that of existing leading brands such as ON! and ZynSo far, the company’s animal studies have evidenced that the technology delivers outstanding results, including faster delivery, an increase in the quantity of peak nicotine delivered, higher brain levels of nicotine, and enhanced bioavailabilityIn its…

Continue Reading

Friday Apr 22, 2022 - 9:00 am

Hero Technologies Inc. (HENC) Looks to Expand as States Report $3.7B in Cannabis Recreational Tax Revenue in 2021

MPP report notes that states with legalized marijuana for adult use generated $3.7 billion in tax revenue from recreational cannabis salesHENC is looking to leverage its cannabis expertise in more of these statesCompany is aggressively pursuing expansion into Colorado, Massachusetts A new report reveals that states with legalized recreational marijuana collected an estimated $3.7 billion in tax revenues last year ( That news bodes well…

Continue Reading

Wednesday Apr 20, 2022 - 9:30 am

Hero Technologies Inc. (HENC) Eyes Passage of Marijuana Act as Plans Include Expansion into Colorado, Massachusetts

U.S. House passes key cannabis bill to remove cannabis from federally banned substancesA 2021 Pew Research Center poll indicates 91% of Americans agree that either medical or recreational cannabis use should be allowedHENC plans to expand into two states — Colorado and Massachusetts — that have legalized cannabis For the second time, the U.S. House of Representatives has passed a bill designed to end the…

Continue Reading

Wednesday Apr 20, 2022 - 9:15 am

Flora Growth Corp. (NASDAQ: FLGC) Celebrates Finalization of Colombian Cannabis Export Protocols

Global cannabis brand Flora Growth Corp. is enjoying new opportunities for supplying its Colombian-grown high-THC and high-CBD flower to international markets, thanks to the finalization of regulatory framework allowing legal cannabis exports from the South American countryFlora Growth is authorized to export non-psychoactive cannabidiol (“CBD”) products as well as up to 43,600 kg of products with high-tetrahydrocannabinol (“THC”) psychoactive cannabis contentFlora Growth’s Cosechemos cultivation facility…

Continue Reading

Monday Apr 18, 2022 - 9:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Advances its Human Nicotine Study and Announces New Nicotine Formulation Creation and Evaluation Program with Altria

Lexaria’s patented DehydraTECH(TM) technology has proven, in the NIC-A21-1 animal study, to be 10-20 times faster in reaching peak delivery of nicotine to the bloodstream than controlsThe company hopes to affirm this in the NIC-H22-1 human nicotine study as their DehydraTECH-nicotine pouch performance will be compared to existing leading brands currently sold in the United States such as ON! and ZynLexaria has separately announced new…

Continue Reading

Tuesday Apr 12, 2022 - 9:15 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Gaining Advantage on Processing Rare Cannabinoids with the Help of Subsidiary Bay Medica

There is an urgent need for large-scale biosynthetic processing that preserves the purity and consistency of cannabinoidsAcquired by InMed in October 2021, Bay Medica is a private U.S. firm specializing in the manufacturing and commercialization of rare cannabinoids for the health and wellness sectorInMed has two cannabinol formulations currently in development for ocular and dermatological diseases – INM-088 (ocular for glaucoma) and INM-755 (dermatological cream…

Continue Reading

Tuesday Apr 12, 2022 - 9:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX): A Review of Its Research Developments

Lexaria Bioscience, the global innovator behind DehydraTECH drug delivery technology, has continuously focused on research into its patented technologyThe company has conducted both in vitro testing and in vivo animal and human testing to evaluate the ability of DehydraTECH to improve the delivery of various APIs (active pharmaceutical ingredients)Lexaria has multiple other studies lined up aimed at building sufficient data to effect meaningful industry and/or…

Continue Reading

Wednesday Apr 06, 2022 - 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Increasing Rare Cannabidiol Product Portfolio, Revenues

InMed Pharmaceuticals is a Canadian clinical-stage drug development company focused on the development of rare cannabinoids and their synthetic counterpoints for B2B sales and pharmaceutical potentialInMed expects to have rare cannabinoids CBDV and THCV available for B2B sale to the health and wellness market in the coming months, following on the heels of its CBC and CBT productsThe company recently reported its first revenues from…

Continue Reading

Wednesday Apr 06, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Multiple Strong Market Paths

Lexaria is a global innovator that has developed the patented DehydraTECH(TM) technology that improves bioavailability, speed of onset, and brain absorption of active pharmaceutical ingredients (“APIs”)The company strategically partners with third-party organizations seeking to explore formulation opportunities with their specific APIsLexaria is evaluating the effectiveness of various DehydraTECH-processed APIs, including CBD, nicotine, sildenafil, and moreAccording to company CEO Chris Bunka, the management team is positioning…

Continue Reading

Monday Apr 04, 2022 - 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF), Building a House of Brands, Is Creating World-Class Standards for Environmental Impact, Social Justice, and Corporate Governance, to Navigate Increasing Commoditization in its Market Segment

Red White & Bloom, a multi-state operator in cannabis and hemp-derived product lines, has built a platform to strengthen its brands, enabling it to wade through the difficulties of increasing product commoditizationThe company expects to showcase the results of the buildout process in the coming monthsRWB is also committed to fostering public and local input, equitable leadership opportunities, and removing systemic structures that marginalize segments…

Continue Reading

Friday Apr 01, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Technology Continues to Showcase Ability to Improve Effectiveness of Existing Drug Brands

Health and wellness drug product innovator Lexaria Bioscience has developed a patented technology — DehydraTECH (TM) — which enhances the bioavailability of fat-soluble drugs and moleculesLexaria continues to research DehydraTECH’s ability to improve the speed and bioavailability of cannabidiol (“CBD”) in treating high blood pressure and epileptic conditionsThe company continues its research demonstrating the ability of its technology -to enhance the performance of antiviral drugs…

Continue Reading

Thursday Mar 31, 2022 - 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Continues to Focus on the Continued Growth of its Top-Line Revenue and Bottom-Line Results in a Move to achieve its 3-Year Success Plan

RWB’s mission has always been to become the superior and most recognizable cannabis company in the United StatesIt seeks to achieve this by focusing on the continued growth of top-line revenue and bottom-line results through brand expansion, mergers, and acquisitionsSo far, in 2022, the company has announced the acquisition of PharmaCo, which sees the transfer of 21 medical and adult-use cannabis licensesRWB has also closed…

Continue Reading

Thursday Mar 31, 2022 - 9:00 am

Hero Technologies Inc. (HENC) Subsidiary Establishes Presence in Booming Colorado Cannabis Market

Cannabis sales in Colorado broke another record last year, topping $2.22 billion in products soldCannabis is “massive” driver of tax revenue for Colorado, raking in over $423 million last year aloneHENC continues to pursue diversification and integration strategy through subsidiary Another record-breaking year for Colorado’s cannabis industry bodes well for Hero Technologies (OTC: HENC). The company anticipates expanding into the booming market via cultivation and dispensary operations through…

Continue Reading

Tuesday Mar 29, 2022 - 9:00 am

Hero Technologies Inc. (HENC) CEO Talks ‘Foot in the Door’ Acquisitions in Recent Bell2Bell Podcast

HENC is focusing on expansion of current operations, future growth in industryCompany aims to be a low-cost, nationally and internationally branded company, become true multistate operator (“MSO”)Recent podcast provides overview of company’s strategic plans, important milestones Key acquisitions and investments have played an essential role in Hero Technologies’ (OTC: HENC)  strategic business plan and operations. As a featured guest during a recent episode of the Bell2Bell…

Continue Reading

Friday Mar 25, 2022 - 9:30 am

Flora Growth Corp. (NASDAQ: FLGC) Reaches Agreements Green-Lighting High-THC Cannabis Exports from Colombia, and Outlets for Premium CBD Skin Care Product in Asia

Cannabis product cultivator Flora Growth Corp. operates a premium growing facility in central Colombia and has received a growing list of authorizations to export its cannabis products for varied health and wellness purposesFlora Growth’s authorized distribution of low-THC CBD cannabis derivatives has been recently expanded to include a quota of up to 43,600 kg of products with high-THC cannabisFlora also reached agreement with Israel-based DNO…

Continue Reading

Tuesday Mar 22, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces First Phase of Epilepsy Research Using DehydraTECH(TM)-CBD

Lexaria’s patented DehydraTECH(TM) technology provides faster delivery times, increases bioavailability, increases brain absorption, improves drug potency, reduces administration costs, and masks unwanted flavorsThe epilepsy research will compare the FDA-approved Epidiolex(R) to the company’s proprietary DehydraTECH-CBD formulationThe global cannabidiol (“CBD”) market had an estimated value of $2.7 billion in 2021 and is expected to reach $111.8 billion by 2030, driven by an increase in demand for…

Continue Reading

Monday Mar 21, 2022 - 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Writing the Playbook on M&A

Flora Growth’s two late 2021 acquisitions added an estimated $35 million in revenue and $7 million in EBITDAIts acquisition of Vessel Brand Inc. is projected to bring $35-$45 million in revenue for the 2022 calendar yearWith these acquisitions, the company, an internationally focused cannabis brand builder with a global distribution platform, stamps its position as an undisputed market and M&A leader In 2021, Flora Growth…

Continue Reading

Friday Mar 18, 2022 - 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Imports First CBD Products from Colombia Operations to U.S., with National Distribution Boost from Recent JustCBD Acquisition

Flora Growth is a cannabis cultivator and distributor operating a 100-hectare (about 247-acre) harvesting site called Cosechemos in central Colombia’s favorable growing climateFlora Growth has completed its first import of CBD-containing food and beverage products into the United States under its Mambe brand, thanks to Colombian regulatory changes in recent months allowing cannabis product exportsFlora has filed licenses for 23 cannabinoid-infused food and beverage products…

Continue Reading

Monday Mar 14, 2022 - 9:30 am

Hero Technologies Inc. (HENC) Applies for Listing on OTCQB, Committed to Inform and Engage Investors

CEO affirms “it is essential that our shareholders and other investors understand that we are committed to sharing information transparently”OTCQB helps companies build shareholder value with a goal of enhancing liquidity and achieving fair valuationHENC also hopes to engage several entities, individuals and influencers to post on social media sites In a strategic move designed to inform and engage investors, Hero Technologies (OTC: HENC) has applied…

Continue Reading

Thursday Mar 10, 2022 - 11:30 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Builds Quality, Consistency in Florida, Michigan Operations

Red White & Bloom Brands is a cannabis and hemp multi-state operator, focused on product consistency and quality, critical to the developing cannabis market that is rapidly growing state by stateThe company’s successes in Michigan, a leading U.S. cannabis market, include the acquisition of full licensing, a 15,000-square-foot manufacturing and distribution facility, and more than 20 new potential locations for cultivation and dispensariesIn Florida, RWB…

Continue Reading

Wednesday Mar 09, 2022 - 9:30 am

Flora Growth Corp. (NASDAQ: FLGC) Strengthens Foothold in U.S. Wellness Market with Acquisition of JustCBD, Appoints Jessie Casner as CMO

Flora Growth owns and operates a portfolio of brands offering wholesale products, consumer packaged goods, or pharmaceutical and medical productsThe three-pronged operational approach has allowed the company to substantially expand and accelerate its revenue growth over the short termRecently, Flora Growth added yet another brand, JustCBD, to its portfolio; JustCBD’s performance is expected to immediately contribute to FLGC’s 2022 revenues and earningsFlora Growth also appointed…

Continue Reading

Tuesday Mar 08, 2022 - 9:00 am

Advanced Container Technologies Inc. (ACTX) Is ‘One to Watch’

ACTX is the exclusive U.S. distributor of Grow Pods, environmentally controlled micro-farms that allow cultivation of ultra-clean crops year-roundACTX is exploring the acquisition of the assets and the assumption of some or all of the liabilities of GP Solutions Inc., the developer and manufacturer of Grow PodsATCX is established in the rapidly growing cannabis packaging industryThe company is well positioned in multiple recession-resistant markets Advanced…

Continue Reading

Friday Mar 04, 2022 - 3:14 pm

ZJ Events Presents Alternative Products Expo to Discuss the Potential of the Alternative Products Ecosystem

Vendors, businesses, industries, CBD & alternative product vendors, researchers, and professionals are invited to attend the Alternative Products Expo at Fort Lauderdale on March 11-13th, 2022. Organized by ZJ Events, the event group is committed to bringing the industry’s best alternative products traders, vendors, and enthusiasts under one platform, while offering a fun and enriching experience. Alternative Products Expo is evolving to include a wide…

Continue Reading

Friday Mar 04, 2022 - 9:15 am

Studies Advance Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology for Significantly Improving Pharmaceutical Drugs

Lexaria Bioscience is dedicated to applying its patented technology to pharmaceutical drug offerings to enhance their performance and speed their rate of effective useThe company’s flagship DehydraTECH(TM) technology has delivered numerous successes in studies of its potential for treating high blood pressure and heart disease, nicotine addiction, and virus infectionMost recently, the company reported successes in increasing the speed and effectiveness in a drug treating…

Continue Reading

Wednesday Mar 02, 2022 - 9:15 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) and BayMedica Rare Cannabinoids to Enter Market Q1 2022; Leveraging on Fast-Growing Global Health and Wellness Market

Over 140 rare cannabinoids exist in the cannabis plant – some with the potential to have more therapeutic benefits than those cannabinoids found prominently in the plantInMed and subsidiary BayMedica plan to release several rare cannabinoid products in the first half of 2022 Combination of complementary InMed and BayMedica business models key to increasing shareholders’ value  In 2020, the global health and wellness market reached $4.436…

Continue Reading

Tuesday Mar 01, 2022 - 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Now Controls All Aspects of its Michigan Operations Following PharmaCo’s Acquisition

RWB has received all regulatory approvals and closed its acquisition of PharmaCo, a Michigan-based marijuana companyThis acquisition opens RWB to over 22 properties, including dispensaries and cultivation sites, giving it complete control of all its operations, from cultivating the product to selling itIt marks a key milestone for the company and its shareholders as it continues to execute key components of its growth strategyFor the…

Continue Reading

Monday Feb 28, 2022 - 9:15 am

As It Targets Multiple Large Market Opportunities, Lexaria Bioscience Corp. (NASDAQ: LEXX) Is Leveraging Elaborate Studies to Progressively Remove Risks Associated with Commercialization, Regulation

Leveraging the versatility and benefits of its DehydraTECH(TM) technology, Lexaria is targeting multiple large market opportunities as it attempts to ensure it has multiple paths to successThe technology aims to help companies offering oral drugs, supplements, and nicotine formulations to improve the effectiveness of their existing or planned productsLexaria has undertaken various studies whose findings show the benefits of DehydraTECH-processed products relative to controlsThe company…

Continue Reading

Friday Feb 25, 2022 - 9:30 am

Flora Growth Corp. (NASDAQ: FLGC) Reaches Agreement with Israeli Product Distributor Artos Ltd. for Cannabis Sales

Flora Growth is a cannabis cultivator and distributor with a large cultivation site in central Colombia’s favorable growing climateFlora Growth recently announced an agreement with Israeli product distribution company Artos Ltd. to sell Flora’s high-THC cannabis flower to IsraelisColombia legalized the international export of cannabis flower last year for use in health and wellness industriesIsraelis comprise a large base of medical marijuana users and cannabis-based…

Continue Reading

Thursday Feb 24, 2022 - 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Strengthening Expansion with Licensing and Vertical Integration Strategy

Cannabis and hemp multi-state operator Red White & Bloom Brands has established itself in fast-growing plant derivative markets from Michigan to Florida and CaliforniaMichigan’s new legal adult-use market is proving fertile ground for development, and the company has leased manufacturing facilities and obtained full licensing in the stateThanks to the Michigan developments, Red White & Bloom is also expanding distribution of its Platinum Vape gummies…

Continue Reading

Friday Feb 18, 2022 - 9:30 am

Flora Growth Corp. (NASDAQ: FLGC) Focused On Opportunities in the CBD Industry to Scale Operations

Luis Merchan, Flora Growth’s President and CEO, appeared on a webinar on February 11, 2022, highlighting the opportunities and challenges affecting the CBD industry in key marketsHe has reiterated the company’s commitment to leveraging the industry’s opportunities for the growth of its operations, expansion of its market reach, and value creation for its shareholdersThe CBD industry is projected to be valued at $20 billion by…

Continue Reading

Wednesday Feb 16, 2022 - 11:13 am

Following Successful Sildenafil Animal Study, Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Plans for More Studies in 2022

Lexaria’s animal study could be the first step to developing faster and better acting sildenafil oral formulations The most prominent study for Lexaria in 2022 is HYPER-H21-4, investigating patented DehydraTECH(TM)-CBD for hypertension and heart disease Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced positive findings in an animal study that evaluated DehydraTECH(TM) processing of the phosphodiesterase inhibitor (PDE5 inhibitor) sildenafil as…

Continue Reading

Monday Feb 14, 2022 - 9:45 am

Flora Growth Corp. (NASDAQ: FLGC) Seeks EUA to Test Cannabis Product Against COVID Virus, Building on Early Study Results as it Names New Chief Strategy Officer

Recent research efforts have targeted the potential of cannabis compounds to combat COVID-19 infection as the worldwide pandemic presses forward into its third yearPerhaps most notable among the early-stage research efforts is a study by Oregon State University that found high doses of two specific cannabinoids bound to spike proteins such as COVID’S SARS-CoV-2 and inhibited their potential for infectionCannabis cultivator and brand builder Flora…

Continue Reading

Friday Feb 11, 2022 - 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Technology Shows Promise in Improving Performance, Speed of ED Drugs

Health and wellness drug bio-effectiveness innovator Lexaria Bioscience is advancing human testing of its patented DehydraTECH(TM) technology for the potential treatment of high blood pressure and heart disease Lexaria also recently announced that DehydraTECH boosted the speed and effectiveness of sildenafil in laboratory rats for the potential treatment of erectile dysfunction (“ED”)The company’s statement notes that DehydraTECH-processed sildenafil “delivered 74% more sildenafil into the bloodstream on…

Continue Reading

Wednesday Feb 09, 2022 - 10:00 am

The New England Cannabis Convention To Be Held In Boston

Cannabis growers, traders, industry professionals, and enthusiasts are invited to attend the New England Cannabis Convention (“NECANN”), on March 18-20, 2022. NECANN events, organized since 2014 are considered as one of the largest cannabis events on the east coast. The NECANN events attract a huge number of Hemp, MMJ and Cannabis traders/professionals in the Northeast in the annual Boston Cannabis Convention. These events are the…

Continue Reading

Tuesday Feb 08, 2022 - 12:34 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Summarizes 2021 Milestones, Outlines 2022 Plans and Expectations, in Annual Letter to Shareholders

In 2021, Lexaria conducted several main studies evaluating DehydraTECH-processed CBD and nicotineThe company has big plans for 2022, a year it expects to undertake three ground-breaking studiesLexaria hopes these three major studies will generate sufficient data to support either regulated IND-type applications or to stimulate corporate partnershipsThe company is eying larger national and international applications for DehydraTECH with the aim of generating revenue through licensing…

Continue Reading

Monday Feb 07, 2022 - 12:02 pm

Flora Growth Corp. (NASDAQ: FLGC) Closes January’s Series of Hires, Appointing Joël Reyes as SVP of Global Operations

Joël Reyes’ appointment marks the third appointment in the first month of the 2022 calendar yearMr. Reyes will be responsible for implementing operational excellence across the entire organization, starting with its Columbian activitiesHis appointment comes just in time, following the implementation of the new Colombian law allowing for the export of up to 7,900 kilograms of high-THC cannabis dried flower Flora Growth (NASDAQ: FLGC) embarked…

Continue Reading

Friday Feb 04, 2022 - 10:10 am

BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Journey: From Runners’ Knee to Canada’s 101 Top F&B Start-up List

BevCanna Enterprises Inc is a diversified health & wellness beverage and natural products companies which deals in the manufacture and distribution of both, in-house brands, and white-label clientsThe company currently boasts over 3,000 points of distribution and online through which it retails the company’s market-leading TRACE brand, its Pure Therapy natural health products as well as its various, cannabis infused beverages. BevCanna’s strong execution recently saw…

Continue Reading

Thursday Feb 03, 2022 - 10:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Strengthens Leading Role in Rare Cannabinoid Market Following New Product Launch, Key Acquisition

Cannabicitran is the first of four new rare cannabinoids InMed is planning to launch in the first half of the year to meet growing inbound demandThe launch demonstrates InMed’s ability to produce rare cannabinoids at scale, something only very few companies have achievedBayMedica acquisition, other key achievements in 2021, are positioning the company as a leading supplier of rare cannabinoids in the health and wellness…

Continue Reading

Wednesday Feb 02, 2022 - 1:57 pm

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Sets to Benefit Amid a Rapidly Growing Market

BevCanna is company developing diversified portfolio of health and wellness products for both in-house brands and white-labeled clientsCompany deploys a traditional retail and direct-to-consumer e-commerce model to offer products throughout North AmericaCompany actively explores opportunities within infused beverages market as CBD-infused beverages gain popularity; global market expected to reach US$2 billion by 2026 BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) is a Canada-based diversified…

Continue Reading

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).